The stock of Verastem Inc (NASDAQ: VSTM) has increased by 20.61 when compared to last closing price of 2.96.Despite this, the company has seen a gain of 19.00% in its stock price over the last five trading days. businesswire.com reported 2024-10-17 that BOSTON–(BUSINESS WIRE)–Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced updated data from the Phase 2 RAMP 201 (ENGOTov60/GOG3052) clinical trial evaluating the combination of avutometinib, an oral RAF/MEK clamp, and defactinib, an oral, selective FAK inhibitor, in patients with recurrent low-grade serous ovarian cancer (LGSOC). The data were published as a late-breaking abstract and additional detaile.
Is It Worth Investing in Verastem Inc (NASDAQ: VSTM) Right Now?
The 36-month beta value for VSTM is at 0.17. Analysts have varying views on the stock, with 3 analysts rating it as a “buy,” 1 rating it as “overweight,” 1 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for VSTM is 36.71M, and currently, shorts hold a 6.40% of that float. The average trading volume for VSTM on October 22, 2024 was 669.47K shares.
VSTM’s Market Performance
The stock of Verastem Inc (VSTM) has seen a 19.00% increase in the past week, with a 23.96% rise in the past month, and a -0.56% fall in the past quarter. The volatility ratio for the week is 17.62%, and the volatility levels for the past 30 days are at 8.09% for VSTM. The simple moving average for the past 20 days is 22.37% for VSTM’s stock, with a -49.63% simple moving average for the past 200 days.
Analysts’ Opinion of VSTM
Many brokerage firms have already submitted their reports for VSTM stocks, with Guggenheim repeating the rating for VSTM by listing it as a “Buy.” The predicted price for VSTM in the upcoming period, according to Guggenheim is $13 based on the research report published on September 30, 2024 of the current year 2024.
BTIG Research, on the other hand, stated in their research note that they expect to see VSTM reach a price target of $27. The rating they have provided for VSTM stocks is “Buy” according to the report published on November 21st, 2023.
B. Riley Securities gave a rating of “Buy” to VSTM, setting the target price at $21 in the report published on September 27th of the previous year.
VSTM Trading at 32.44% from the 50-Day Moving Average
After a stumble in the market that brought VSTM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -74.89% of loss for the given period.
Volatility was left at 8.09%, however, over the last 30 days, the volatility rate increased by 17.62%, as shares surge +30.29% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +51.91% upper at present.
During the last 5 trading sessions, VSTM rose by +19.00%, which changed the moving average for the period of 200-days by -57.80% in comparison to the 20-day moving average, which settled at $2.92. In addition, Verastem Inc saw -56.14% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at VSTM starting from Calkins Daniel, who sale 6 shares at the price of $2.86 back on Oct 07 ’24. After this action, Calkins Daniel now owns 47,461 shares of Verastem Inc, valued at $17 using the latest closing price.
Calkins Daniel, the Chief Financial Officer of Verastem Inc, sale 65 shares at $2.80 during a trade that took place back on Sep 20 ’24, which means that Calkins Daniel is holding 47,495 shares at $182 based on the most recent closing price.
Stock Fundamentals for VSTM
Current profitability levels for the company are sitting at:
- -9.77 for the present operating margin
- 1.0 for the gross margin
The net margin for Verastem Inc stands at -8.85. The total capital return value is set at -1.31. Equity return is now at value -109.97, with -60.16 for asset returns.
Based on Verastem Inc (VSTM), the company’s capital structure generated 0.51 points at debt to capital in total, while cash flow to debt ratio is standing at -2.44. The debt to equity ratio resting at 1.05. The interest coverage ratio of the stock is -21.87.
Currently, EBITDA for the company is -92.02 million with net debt to EBITDA at 0.43. When we switch over and look at the enterprise to sales, we see a ratio of 10.1. The receivables turnover for the company is 0.93for trailing twelve months and the total asset turnover is 0.1. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.28.
Conclusion
In conclusion, Verastem Inc (VSTM) has had a mixed performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
